Angioplasty balloons widens the narrow or obstructed blood vessel using a balloon catheter to treat atherosclerosis (blood vessel obstructions). Balloon angioplasty is a minimally invasive procedure that widens the obstructed blood vessels. PTA or PTCA is a minimally invasive catheter based technology that enables treatment of coronary and peripheral artery disease. In this technique balloons are utilized for the clearance of artery which have been blocked due to deposition of fatty material. These balloon catheters compresses the plaques within a blocked coronary or peripheral artery.
The angioplasty balloons market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on balloon type (normal, cutting, drug coated and scoring balloons), materials used (non-compliant and semi-compliant balloons), and forecasts growth trends (CAGR% – 2017 to 2021).
The global angioplasty balloons market segmentation is based on geography (regional and country based). The global angioplasty balloons market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global angioplasty balloons market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players profiled in this report include Abbott Laboratories, Inc., BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, C. R. Bard, Inc., ENDOCOR GmbH, Medtronic plc, Opto Circuits (India) Limited, NATEC Medical, and Spectranetics Corporation.